| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |